Jim Sullivan is the founder of Vanqua Bio. Vanqua Bio has raised $85M in total funding. Latest round: Series B. Based in Boston, MA.
Jim Sullivan is the Co-founder and Chief Executive Officer of Vanqua Bio, a Chicago-based biopharmaceutical company focused on developing next-generation medicines for neurodegenerative diseases. The company uses advanced insights into neuronal cell pathways and cutting-edge assays to create new therapies for conditions like Parkinson's, Alzheimer's, and ALS. Vanqua Bio secured an $85 million Series B financing round in September 2021, following an initial Series A funding from OrbiMed in 2019. Sullivan, a neuroscientist by training, has extensive experience in biotech and pharma, including a career at Abbvie where he contributed to the discovery and development of several therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library